Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:02am, Tuesday, May 06, 2025
Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) has recently released its Q1 2025 financial results, showcasing a mix of promising developments and notable challenges.
Key Highlights from the Income Statement:
Net Interest Income: Increased by 17.6% year-over-year to $10.1 million.
Interest Income: R...
09:02am, Tuesday, May 06, 2025
CorMedix Inc. (NYSE: CRMD) has released its financials for the quarter ended March 31, 2025. The company is focused on commercializing its lead product, DefenCath, an FDA-approved antimicrobial catheter lock solution designed to reduce bloodstream infections in patients undergoing chronic hemodia...
09:01am, Tuesday, May 06, 2025
Douglas Elliman Inc. (NYSE: DOUG) has released its quarterly financial report for the period ended March 31, 2025. Here’s a summary of key financial insights:
Positive Aspects:
Revenue Growth: Total revenues increased to $253.4 million from $200.2 million year-over-year, highlighting a strong de...
09:01am, Tuesday, May 06, 2025
Vishay Precision Group, Inc. (NYSE: VPG) recently reported its financial results for the fiscal quarter ending March 29, 2025. The results illustrate a challenging quarter for the company amid changing market dynamics.
Key Financial Highlights:
Net Revenues: $71.7 million, down 11.2% from $80.8 ...
09:01am, Tuesday, May 06, 2025
Company Overview: Amalgamated Financial Corp. (NASDAQ: AMAL) focuses on socially responsible banking, primarily serving advocacy-based non-profits and socially conscious businesses. As of March 31, 2025, their total assets reached $8.29 billion, with $4.62 billion in net loans and $7.41 billion i...
09:00am, Tuesday, May 06, 2025
Company Overview: Ichor Holdings, Ltd. (NASDAQ: ICHR) is a leader in the design and manufacturing of critical fluid delivery systems for semiconductor capital equipment. Their products are essential for processes in semiconductor manufacturing, where precision is critical.
Recent Financial Perfor...
08:07am, Tuesday, May 06, 2025
Pediatrix Medical Group, Inc. (NYSE: MD) has released its quarterly results for the period ending March 31, 2025. The company, a leading provider of physician services including newborn and pediatric care, reported mixed results in its income statement and continued to navigate various operationa...
08:06am, Tuesday, May 06, 2025
Waters Corporation (NYSE: WAT) - Q1 2025 Financial Overview
Waters Corporation has released its financial results for the first quarter ended March 29, 2025. The company achieved a 4% year-over-year increase in total net sales, primarily due to rising customer demand for its liquid chromatography...
08:06am, Tuesday, May 06, 2025
Orthofix Medical Inc. (NASDAQ: OFIX)
As of the first quarter of 2025, Orthofix Medical Inc. has released its financial results, revealing a mixed performance. Below are key points from the income statement and other relevant corporate updates:
Net Sales: $193.6 million, up 2.7% from $188.6 milli...
08:06am, Tuesday, May 06, 2025
First Watch Restaurant Group, Inc. (NASDAQ: FWRG) reports its first quarter results for 2025, showing mixed performance and challenges in a competitive market. The company operates and franchises restaurants focused on breakfast, brunch, and lunch across 30 states in the U.S.
Key Highlights:
Tot...
08:05am, Tuesday, May 06, 2025
Company OverviewUpstream Bio, Inc. (NASDAQ: UPB) is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory diseases, primarily severe respiratory disorders. They are currently advancing their only product candidate, verekitug, which targets the Thymic Stromal...
08:05am, Tuesday, May 06, 2025
Fabrinet (NYSE: FN) - Q3 Financial Overview
Key Highlights:
Revenues: Increased by 19.2% to $871.8 million in Q3 2025 from $731.5 million in Q3 2024.
Net Income: Rose to $81.3 million (9.3% of revenues) compared to $80.9 million (11.1% of revenues) year-over-year.
Gross Profit: Improved to $102....
08:04am, Tuesday, May 06, 2025
QNB Corp. (OTCMKTS: QNBC) - Q1 2025 Financial Overview
Company Highlights:
Net Income: $2.578 million, or $0.69 per diluted share, down from $2.594 million, or $0.71 per diluted share in Q1 2024.
Net Interest Income: Increased by 13.46% to $11.537 million, driven by higher loan and securities in...
08:04am, Tuesday, May 06, 2025
Company Overview: Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotechnology firm focused on developing precision genetic medicines. As of March 31, 2025, the company reported substantial advancements in its clinical programs but continues to incur significant losses.
Key Financial Highlights:
Lic...
08:03am, Tuesday, May 06, 2025
TScan Therapeutics, Inc. (NYSE: TCRX) continues to navigate a challenging landscape as a biotechnology company focused on developing innovative T cell receptor (TCR)-engineered therapies for cancer treatment. Recent developments reflect both promising advancements and significant financial hurdle...